126 related articles for article (PubMed ID: 298337)
1. Interactions of amphetamine, pimozide, and lithium on plasma norepineophrine and dopamine-beta-hydroxylase in schizophrenic patients.
Rosenblatt JE; Lake CR; van Kammen DP; Ziegler MG; Bunney WE
Psychiatry Res; 1979 Jul; 1(1):45-52. PubMed ID: 298337
[TBL] [Abstract][Full Text] [Related]
2. Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia.
Castellani S; Ziegler MG; van Kammen DP; Alexander PE; Siris SG; Lake CR
Arch Gen Psychiatry; 1982 Oct; 39(10):1145-9. PubMed ID: 7125844
[TBL] [Abstract][Full Text] [Related]
3. The hyperactive child syndrome: peripheral sympathetic nervous system function and the effect of d-amphetamine.
Mikkelsen E; Lake CR; Brown GL; Ziegler MG; Ebert MH
Psychiatry Res; 1981 Apr; 4(2):157-69. PubMed ID: 6939007
[TBL] [Abstract][Full Text] [Related]
4. Lack of behavioral supersensitivity to d-amphetamine after pimozide withdrawal. A trial with schizophrenic patients.
van Kammen DP; Docherty JP; Marder SR; Schulz SC; Bunney WE
Arch Gen Psychiatry; 1980 Mar; 37(3):287-90. PubMed ID: 6102456
[TBL] [Abstract][Full Text] [Related]
5. Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram.
Lake CR; Major LF; Ziegler MG; Kopin IJ
Am J Psychiatry; 1977 Dec; 134(12):1411-4. PubMed ID: 920841
[TBL] [Abstract][Full Text] [Related]
6. Prediction of early relapse after pimozide discontinuation by response to d-amphetamine during pimozide treatment.
van Kammen DP; Docherty JP; Bunney WE
Biol Psychiatry; 1982 Feb; 17(2):233-42. PubMed ID: 7074181
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines and dopamine-beta-hydroxylase activity during therapeutic abortion induced by sulprostone.
Saarikoski S; Selander K; Nukala E; Pystynen P
Prostaglandins; 1980 Sep; 20(3):487-92. PubMed ID: 7422895
[TBL] [Abstract][Full Text] [Related]
8. High dose pimozide does not block amphetamine-induced euphoria in normal volunteers.
Brauer LH; De Wit H
Pharmacol Biochem Behav; 1997 Feb; 56(2):265-72. PubMed ID: 9050084
[TBL] [Abstract][Full Text] [Related]
9. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers.
Brauer LH; de Wit H
Biol Psychiatry; 1996 Jan; 39(1):26-32. PubMed ID: 8719123
[TBL] [Abstract][Full Text] [Related]
10. d-Amphetamine raises serum prolactin in man: evaluations after chronic placebo, lithium and pimozide treatment.
van Kammen DP; Docherty JP; Marder SR; Siris SG; Bunney WE
Life Sci; 1978 Oct; 23(14):1487-92. PubMed ID: 362103
[No Abstract] [Full Text] [Related]
11. Implications for multiple transmitter mediation of amphetamine-induced stereotypies.
Cheal M; Kurkulos ME; Silva L
Pharmacol Biochem Behav; 1982 Dec; 17(6):1305-8. PubMed ID: 6891794
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation of plasma norepinephrine and dopamine-beta-hydroxylase in hypertensive and normotensive subjects.
Lake CR; Ziegler MG; Coleman M; Kopin IJ
Circ Res; 1977 Dec; 41(6):865-9. PubMed ID: 923037
[TBL] [Abstract][Full Text] [Related]
13. Effects of exogenous prostaglandin E1 on human plasma norepinephrine level and dopamine-beta-hydrolyxase activity.
Ogawa K; Ito T; Ban M; Matsuno T; Shiozu H; Tsutiya S; Enomoto K
Acta Biol Med Ger; 1978; 37(5-6):845-8. PubMed ID: 217212
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic effects of pimozide in schizophrenia. Treatment response prediction with acute dextroamphetamine response.
van Kammen DP; Docherty JP; Marder SR; Schulz SC; Dalton L; Bunney WE
Arch Gen Psychiatry; 1982 Mar; 39(3):261-6. PubMed ID: 7065839
[TBL] [Abstract][Full Text] [Related]
15. Lithium attenuates the activation-euphoria but not the psychosis induced by d-amphetamine in schizophrenia.
van Kammen DP; Docherty JP; Marder SR; Rosenblatt JE; Bunney WE
Psychopharmacology (Berl); 1985; 87(1):111-5. PubMed ID: 3933028
[TBL] [Abstract][Full Text] [Related]
16. Long-term pimozide pretreatment differentially affects behavioral responses to dextroamphetamine in schizophrenia. Further exploration of the dopamine hypothesis of schizophrenia.
van Kammen DP; Docherty JP; Marder SR; Rayner JN; Bunney WE
Arch Gen Psychiatry; 1982 Mar; 39(3):275-81. PubMed ID: 6802100
[TBL] [Abstract][Full Text] [Related]
17. Plasma norepinephrine concentration and plasma dopamine-beta-hydroxylase activity in patients with congestive heart failure.
Minami M; Yasuda H; Yamazaki N; Kojima S; Nishijima H; Matsumura N; Togashi H; Koike Y; Saito H
Circulation; 1983 Jun; 67(6):1324-9. PubMed ID: 6851028
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-beta-hydroxylase activity and catecholamine levels in the plasma of patients with renal failure.
Ksiazek A
Nephron; 1979; 24(4):170-3. PubMed ID: 492427
[TBL] [Abstract][Full Text] [Related]
19. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals.
Weinshenker D; Miller NS; Blizinsky K; Laughlin ML; Palmiter RD
Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13873-7. PubMed ID: 12370425
[TBL] [Abstract][Full Text] [Related]
20. Plasma and lymph dopamine-beta-hydroxylase and norepinephrine during carotid occlusion.
Velasquez MT; Alexander N
Am J Physiol; 1979 Jan; 236(1):H96-100. PubMed ID: 434180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
